CD96 and neoplasm: Supporting a role for CD226 and CD96 in the context of tumour evasion, a study of patients with pancreatic cancer demonstrated that CD226+CD96+ NK cells are deficient in patients versus healthy controls, while TIGIT was not altered [26].